Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veronica Balatti

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Journal of Hematology & Oncology|November 21, 2019
Genetic dynamics in untreated CLL patients with either stable or progressive disease: a longitudinal studyAlice Ramassone, Andrea D'Argenio, Angelo Veronese, et al.
The Journal of Experimental Medicine|April 24, 2013
In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulationFlavia Pichiorri, Dario Palmieri, Luciana De Luca, et al.
The Journal of Experimental Medicine|January 21, 2017
Correction: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulationFlavia Pichiorri, Dario Palmieri, Luciana De Luca, et al.
The Journal of Experimental Medicine|June 30, 2026
Retraction: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulationFlavia Pichiorri, Dario Palmieri, Luciana De Luca, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 12, 2017
tsRNA signatures in cancerVeronica Balatti, Giovanni Nigita, Dario Veneziano, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Journal of Hematology & Oncology|November 21, 2019
Genetic dynamics in untreated CLL patients with either stable or progressive disease: a longitudinal studyAlice Ramassone, Andrea D'Argenio, Angelo Veronese, et al.
The Journal of Experimental Medicine|April 24, 2013
In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulationFlavia Pichiorri, Dario Palmieri, Luciana De Luca, et al.
The Journal of Experimental Medicine|January 21, 2017
Correction: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulationFlavia Pichiorri, Dario Palmieri, Luciana De Luca, et al.
The Journal of Experimental Medicine|June 30, 2026
Retraction: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulationFlavia Pichiorri, Dario Palmieri, Luciana De Luca, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 12, 2017
tsRNA signatures in cancerVeronica Balatti, Giovanni Nigita, Dario Veneziano, et al.
Pageof 5